Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingalls

Showing results (321-330 of 418) with videos related to

Pageof 42
Sort By:
The ISME Journal|February 19, 2025
Lysis of Escherichia coli by colicin Ib contributes to bacterial cross-feeding by releasing active β-galactosidaseNicole A Lerminiaux, Jaycee M Kaufman, Laura J Schnell, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerA Dowlati, N Levitan, N H Gordon, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitrilesRussell G Dushin, Thomas Nittoli, Charles Ingalls, et al.
Emergency Medicine Journal : EMJ|January 3, 2023
Performance of three screening tools to predict COVID-19 positivity in emergency department patientsMadeline A DiLorenzo, Megan R Davis, Julianne N Dugas, et al.
Plos One|October 17, 2022
Expert-generated standard practice elements for evidence-based home visiting programs using a Delphi processEmily E Haroz, Allison Ingalls, Karla Decker Sorby, et al.
Bioorganic & Medicinal Chemistry|April 10, 2007
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2Allan Wissner, Heidi L Fraser, Charles L Ingalls, et al.
Journal of Clinical Pharmacology|September 5, 2003
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanineKou-Yi Tserng, Stephen T Ingalls, Erik M Boczko, et al.
The Journal of Trauma and Acute Care Surgery|February 14, 2012
Early treatment of blunt cerebrovascular injury with concomitant hemorrhagic neurologic injury is safe and effectiveRachael A Callcut, Dennis J Hanseman, Patrick D Solan, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Spatial Multi-Omics Workflow and Analytical Guidelines for Alzheimer's NeuropathologyXuehan Sun, Hannah R Hudson, Timothy C Orr, et al.
Advanced Healthcare Materials|January 7, 2022
Encapsulation of Primary Salivary Gland Acinar Cell Clusters and Intercalated Ducts (AIDUCs) within Matrix Metalloproteinase (MMP)-Degradable Hydrogels to Maintain Tissue Structure and FunctionYuanhui Song, Azmeer Sharipol, Hitoshi Uchida, et al.
Pageof 42

Showing results (321-330 of 418) with videos related to

Sort By:
Pageof 42
The ISME Journal|February 19, 2025
Lysis of Escherichia coli by colicin Ib contributes to bacterial cross-feeding by releasing active β-galactosidaseNicole A Lerminiaux, Jaycee M Kaufman, Laura J Schnell, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerA Dowlati, N Levitan, N H Gordon, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitrilesRussell G Dushin, Thomas Nittoli, Charles Ingalls, et al.
Emergency Medicine Journal : EMJ|January 3, 2023
Performance of three screening tools to predict COVID-19 positivity in emergency department patientsMadeline A DiLorenzo, Megan R Davis, Julianne N Dugas, et al.
Plos One|October 17, 2022
Expert-generated standard practice elements for evidence-based home visiting programs using a Delphi processEmily E Haroz, Allison Ingalls, Karla Decker Sorby, et al.
Bioorganic & Medicinal Chemistry|April 10, 2007
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2Allan Wissner, Heidi L Fraser, Charles L Ingalls, et al.
Journal of Clinical Pharmacology|September 5, 2003
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanineKou-Yi Tserng, Stephen T Ingalls, Erik M Boczko, et al.
The Journal of Trauma and Acute Care Surgery|February 14, 2012
Early treatment of blunt cerebrovascular injury with concomitant hemorrhagic neurologic injury is safe and effectiveRachael A Callcut, Dennis J Hanseman, Patrick D Solan, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Spatial Multi-Omics Workflow and Analytical Guidelines for Alzheimer's NeuropathologyXuehan Sun, Hannah R Hudson, Timothy C Orr, et al.
Advanced Healthcare Materials|January 7, 2022
Encapsulation of Primary Salivary Gland Acinar Cell Clusters and Intercalated Ducts (AIDUCs) within Matrix Metalloproteinase (MMP)-Degradable Hydrogels to Maintain Tissue Structure and FunctionYuanhui Song, Azmeer Sharipol, Hitoshi Uchida, et al.
Pageof 42